Strs Ohio Amgen Inc Transaction History

Strs Ohio

$24.9 Billion
Q2 2024

A detailed history of Strs Ohio transactions in Amgen Inc stock. As of the latest transaction made, Strs Ohio holds 173,467 shares of AMGN stock, worth $55.9 Million. This represents 0.22% of its overall portfolio holdings.

Number of Shares

173,467

Previous 178,470 2.8%

Holding current value

$55.9 Million

Previous $50.7 Million 6.81%

% of portfolio

0.22%

Previous 0.21%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 05, 2024	SELL	$262.75 - $319.31 $1.31 Million - $1.6 Million	-5,003 Reduced 2.8%	173,467 $54.2 Million
Q1 2024 May 13, 2024	SELL	$268.87 - $324.56 $4.39 Million - $5.3 Million	-16,345 Reduced 8.39%	178,470 $50.7 Million
Q4 2023 Jan 30, 2024	SELL	$255.7 - $288.46 $1.16 Million - $1.31 Million	-4,553 Reduced 2.28%	194,815 $56.1 Million
Q3 2023 Oct 26, 2023	SELL	$218.65 - $271.46 $1.16 Million - $1.44 Million	-5,295 Reduced 2.59%	199,368 $53.6 Million
Q2 2023 Jul 31, 2023	BUY	$214.27 - $253.37 $43.9 Million - $51.9 Million	204,663 New	204,663 $45.4 Million
Q1 2023 Aug 02, 2023	BUY	$225.79 - $275.2 $2.22 Million - $2.71 Million	9,852 Added 4.81%	214,515 $51.9 Million
Q4 2022 Jan 26, 2023	BUY	$229.03 - $291.01 $1.39 Million - $1.77 Million	6,073 Added 2.9%	215,553 $56.6 Million
Q3 2022 Oct 27, 2022	SELL	$224.46 - $253.15 $3.51 Million - $3.96 Million	-15,628 Reduced 6.94%	209,480 $47.2 Million
Q2 2022 Jul 25, 2022	SELL	$230.71 - $256.74 $3.97 Million - $4.42 Million	-17,218 Reduced 7.11%	225,108 $54.8 Million
Q1 2022 Apr 21, 2022	BUY	$219.27 - $242.57 $552,341 - $611,033	2,519 Added 1.05%	242,326 $58.6 Million
Q4 2021 Jan 24, 2022	BUY	$198.88 - $227.6 $12.6 Million - $14.5 Million	63,504 Added 36.02%	239,807 $53.9 Million
Q3 2021 Oct 22, 2021	SELL	$212.27 - $248.7 $3.66 Million - $4.29 Million	-17,255 Reduced 8.91%	176,303 $37.5 Million
Q2 2021 Jul 26, 2021	SELL	$233.58 - $259.14 $4.19 Million - $4.64 Million	-17,917 Reduced 8.47%	193,558 $47.2 Million
Q1 2021 Apr 23, 2021	SELL	$221.91 - $258.6 $8.88 Million - $10.3 Million	-40,020 Reduced 15.91%	211,475 $52.6 Million
Q4 2020 Jan 25, 2021	SELL	$216.38 - $257.67 $5.66 Million - $6.74 Million	-26,161 Reduced 9.42%	251,495 $57.8 Million
Q3 2020 Dec 14, 2020	SELL	$234.65 - $260.95 $6.33 Million - $7.04 Million	-26,962 Reduced 8.85%	277,656 $70.6 Million
Q2 2020 Jul 23, 2020	BUY	$197.81 - $242.74 $916,058 - $1.12 Million	4,631 Added 1.54%	304,618 $71.8 Million
Q1 2020 Apr 23, 2020	BUY	$182.24 - $241.7 $6.82 Million - $9.04 Million	37,417 Added 14.25%	299,987 $60.8 Million
Q4 2019 Jan 24, 2020	SELL	$189.21 - $243.2 $3.82 Million - $4.92 Million	-20,214 Reduced 7.15%	262,570 $63.3 Million
Q3 2019 Oct 21, 2019	SELL	$174.11 - $208.62 $1.61 Million - $1.93 Million	-9,242 Reduced 3.16%	282,784 $54.7 Million
Q2 2019 Jul 25, 2019	SELL	$166.7 - $195.41 $1.8 Million - $2.11 Million	-10,811 Reduced 3.57%	292,026 $53.8 Million
Q1 2019 Apr 19, 2019	SELL	$180.87 - $203.88 $1.34 Million - $1.51 Million	-7,401 Reduced 2.39%	302,837 $57.5 Million
Q4 2018 Jan 23, 2019	SELL	$178.4 - $208.25 $328,969 - $384,013	-1,844 Reduced 0.59%	310,238 $60.4 Million
Q3 2018 Oct 19, 2018	SELL	$185.29 - $208.89 $13.2 Million - $14.9 Million	-71,122 Reduced 18.56%	312,082 $64.7 Million
Q2 2018 Aug 06, 2018	SELL	$166.05 - $186.51 $6.35 Million - $7.13 Million	-38,227 Reduced 9.07%	383,204 $70.7 Million
Q1 2018 Apr 20, 2018	SELL	$169.43 - $198.0 $3.74 Million - $4.37 Million	-22,088 Reduced 4.98%	421,431 $71.8 Million
Q4 2017 Jan 23, 2018	SELL	$168.79 - $188.59 $1.46 Million - $1.63 Million	-8,627 Reduced 1.91%	443,519 $77.1 Million
Q3 2017 Oct 23, 2017	BUY	$167.29 - $191.0 $75.6 Million - $86.4 Million	452,146	452,146 $84.3 Million

Others Institutions Holding AMGN

# of Institutions

3,055

Shares Held

409M

Call Options Held

7.19M

Put Options Held

6.26M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $172B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.

Account